Lisata Therapeutics
LSTA1.0315.41% ( -0.059 )
Lisata Therapeutics (LSTA)
Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment...
- Open
- 1.080
- High
- 1.080
- Low
- 1.020
- Prev. Close
- 1.090
- Volume
- 49.42K
- Turnover
- 51.83K
- Avg Price
- 1.049
- Bid/Ask Ratio
- --
- Amplitude
- 5.50%
- 52wk High
- 5.070
- Volume Ratio
- 0.32
- Turnover Ratio
- 0.69%
Lisata Therapeutics Analyst Rating
View MoreForecast & Rating
Jul 27, 2026Price forecast
$4.00277.71%
Forecast & RatingHold
2analysts
- Strong buy0.00%
- Buy0.00%
- Hold100.00%
- Sell0.00%
- Strong sell0.00%
News
- TradingView · Jul 24 at 11:23 AM
Lisata Therapeutics Terminates Kuva Labs Merger After Financing Failure; To Receive $2 Million Fee
- benzinga_article · Jul 22 at 12:03 AM
Lisata Therapeutics Stock Falls After Hours: Here's Why
- benzinga_article · Jul 21 at 12:05 PM
12 Health Care Stocks Moving In Tuesday's Intraday Session
- benzinga_article · Jul 21 at 07:05 AM
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- PUBT · Jul 17 at 06:02 AM
Lisata Therapeutics, Kuva Labs extend merger agreement outside date to July 21
- Price Alert · Jul 14 at 05:07 AM
Pre-market hot trades in US stocks: Lisata Therapeutics pre-market down 13.24%; Applied Materials pre-market up 3.67%
